Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Théoleyre

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 11, 2015
EGFR T790M resistance mutation in non small-cell lung carcinomaMarc G Denis, Audrey Vallée, Sandrine Théoleyre
Biochemical and Biophysical Research Communications|December 3, 2009
HtrA3 is regulated by 15-deoxy-Delta12,14-prostaglandin J2 independently of PPARgamma in clear cell renal cell carcinomasSandrine Théoleyre, Stéphanie Mottier, Damien Masson, et al.
Cytokine & Growth Factor Reviews|January 30, 2004
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiologySteeve Kwan Tat, Marc Padrines, Sandrine Théoleyre, et al.
Plos One|August 16, 2019
Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assayAudrey Vallée, Marie Denis-Musquer, Guillaume Herbreteau, et al.
Translational Lung Cancer Research|May 22, 2026
Methylated circulating tumor DNA: technical challenges and clinical applications in non-small cell lung cancer patients-a narrative reviewManon Robert, Chloé Sauzay, Sandrine Théoleyre, et al.
Annales De Biologie Clinique|December 2, 2017
Circulating tumour DNA: analytical aspects and clinical applications for metastatic melanoma patientsGuillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
Cancers|August 27, 2021
MEM: An Algorithm for the Reliable Detection of Microsatellite Instability (MSI) on a Small NGS Panel in Colorectal CancerGuillaume Herbreteau, Fabrice Airaud, Elise Pierre-Noël, et al.
Oncotarget|June 5, 2018
Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapyGuillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
International Journal of Cancer|June 25, 2009
KLF4-dependent, PPARgamma-induced expression of GPA33 in colon cancer cell linesJulie Rageul, Stéphanie Mottier, Anne Jarry, et al.
Cancers|April 30, 2021
Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation StudyGuillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 11, 2015
EGFR T790M resistance mutation in non small-cell lung carcinomaMarc G Denis, Audrey Vallée, Sandrine Théoleyre
Biochemical and Biophysical Research Communications|December 3, 2009
HtrA3 is regulated by 15-deoxy-Delta12,14-prostaglandin J2 independently of PPARgamma in clear cell renal cell carcinomasSandrine Théoleyre, Stéphanie Mottier, Damien Masson, et al.
Cytokine & Growth Factor Reviews|January 30, 2004
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiologySteeve Kwan Tat, Marc Padrines, Sandrine Théoleyre, et al.
Plos One|August 16, 2019
Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assayAudrey Vallée, Marie Denis-Musquer, Guillaume Herbreteau, et al.
Translational Lung Cancer Research|May 22, 2026
Methylated circulating tumor DNA: technical challenges and clinical applications in non-small cell lung cancer patients-a narrative reviewManon Robert, Chloé Sauzay, Sandrine Théoleyre, et al.
Annales De Biologie Clinique|December 2, 2017
Circulating tumour DNA: analytical aspects and clinical applications for metastatic melanoma patientsGuillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
Cancers|August 27, 2021
MEM: An Algorithm for the Reliable Detection of Microsatellite Instability (MSI) on a Small NGS Panel in Colorectal CancerGuillaume Herbreteau, Fabrice Airaud, Elise Pierre-Noël, et al.
Oncotarget|June 5, 2018
Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapyGuillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
International Journal of Cancer|June 25, 2009
KLF4-dependent, PPARgamma-induced expression of GPA33 in colon cancer cell linesJulie Rageul, Stéphanie Mottier, Anne Jarry, et al.
Cancers|April 30, 2021
Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation StudyGuillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
Pageof 2